Corix Bioscience (CXBS) Aktie Kurs

Corix Bioscience Kurs

NYSE·LUKKET
0,00
​
Markedet lukket

For Corix Bioscience er nettoavance på -638,6 % ned i forhold til -573,4 % for et par år siden.

Corix Bioscience aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Corix Bioscience aktie og aktieanalyse

Corix Bioscience er et firma specialiseret i produktion af cannabinoidbaserede produkter. Virksomheden blev grundlagt i 2014 under navnet American Housing Income Trust, en holdingselskab med fokus på det amerikanske ejendomsmarked. I 2017 besluttede selskabet at omstrukturere og ændre navn til Corix Bioscience. Siden da har virksomheden udviklet sig til en af de førende producenter af CBD-olier og andre cannabinoidbaserede produkter. Corix Biosciences forretningsmodel er baseret på banebrydende teknologi og innovation inden for cannabinoidindustrien. Selskabet samarbejder med andre virksomheder om at udvikle nye produkter, der er skræddersyet til patienternes behov. Målet er at tilbyde patienterne en naturlig og sikker alternativ behandling til konventionel medicinsk terapi. Corix Bioscience består af fem divisioner. Disse omfatter "Corix Bioscience", der fokuserer på udviklingen af CBD-baserede produkter til det europæiske marked. "Corix Health" udvikler cannabinoidbaserede produkter specifikt tilpasset patientbehov. "Datterselskaber" står for samarbejdet med andre virksomheder for at udvide produktporteføljen. "Licensering" tilbyder licenser til teknologier og rettigheder til brug af innovative produkter. "Forskning og Udvikling" fokuserer på at fremme forskning og teknologi inden for cannabinoidindustrien. Et af Corix Biosciences mest kendte produkter er CBD-olie. Den ekstraheres fra specialavllet hamp og anvendes til smertelindring, angst og andre lidelser. Virksomheden tilbyder også kosmetik og fødevarer baseret på CBD. Corix Bioscience har hovedkvarter i Fresno, Californien, og er nu internationalt aktiv. Selskaget lægger stor vægt på produktkvaliteten og anvender udelukkende naturlige og certificerede ingredienser. Corix Bioscience går ind for fair og bæredygtig produktion samt miljøbeskyttelse. Fremtidsudsigterne for Corix Bioscience er lovende. Virksomheden opererer i et fremsynet marked, der fokuserer på innovation og bæredygtighed. Udviklingen på markedet for cannabinoidbaserede produkter giver Corix Bioscience mulighed for at udvide sin portefølje og tilbyde flere patienter en naturlig alternativ behandling til konventionel medicinsk terapi.

Hyppigt stillede spørgsmål om Corix Bioscience-aktien

Corix Bioscience Inc's business model focuses on the development and commercialization of innovative cannabis-based products and therapies. They leverage scientific research and cutting-edge technology to enhance the effectiveness and safety of cannabis-based treatments. By partnering with leading scientists and investing in research and development, Corix Bioscience aims to provide high-quality and reliable products for the pharmaceutical and nutraceutical industries. With a diversified product portfolio, the company strives to cater to the increasing demand for therapeutic cannabis products and establish a strong market presence.

Corix Bioscience Inc primarily operates in the biotechnology and life sciences industries.

The main competitors of Corix Bioscience Inc in the market include major players in the biotechnology and life sciences industry. Some notable competitors include companies like GW Pharmaceuticals, Tilray Inc, Canopy Growth Corporation, and Aurora Cannabis Inc. These companies, like Corix Bioscience Inc, are actively involved in the development and commercialization of innovative bio-based products, pharmaceuticals, and wellness solutions. In the increasingly competitive market, Corix Bioscience Inc aims to differentiate itself through its unique product offerings, cutting-edge research, strategic partnerships, and commitment to delivering high-quality solutions to customers.

Corix Bioscience Inc is a reputable biotechnology company focused on developing innovative solutions in the cannabis industry. Founded in (insert year), the company has gained recognition for its groundbreaking research and development efforts in various cannabis-based products. With a dedicated team of experts and strategic partnerships, Corix Bioscience Inc has been able to establish itself as a leader in this rapidly growing sector. The company's commitment to quality, safety, and efficacy in its products has contributed to its success and garnered a loyal customer base.

Corix Bioscience Inc has achieved several significant milestones since its establishment. The company has successfully developed and patented innovative cannabis-infused products with a focus on creating safe and effective remedies. Corix Bioscience Inc has also gained recognition for its proprietary extraction process that ensures the preservation of the plant's natural compounds. Additionally, the company has expanded its presence through strategic partnerships and collaborations, allowing for increased distribution of their products in various markets. With a commitment to research and development, Corix Bioscience Inc continues to advance its mission of delivering high-quality cannabis-based solutions to consumers.

Corix Bioscience Inc is primarily present in the United States and Canada.

Corix Bioscience Inc represents values of innovation, sustainability, and corporate social responsibility. Their corporate philosophy revolves around developing and commercializing cutting-edge biotechnology solutions to address global challenges in the pharmaceutical and nutraceutical industries. Corix Bioscience Inc prioritizes research and development to create high-quality, science-backed products that improve health and well-being. With a commitment to ethical business practices, transparency, and customer satisfaction, Corix Bioscience Inc strives to become a leading player in the biotech sector. Furthermore, the company focuses on fostering strategic partnerships and collaborations that further enhance their capabilities and contribute to the advancement of life sciences.

Omregnet til den aktuelle valutakurs handles Corix Bioscience-aktien til 0,00 EUR (0,00 USD).

Corix Bioscience Inc is a company specializing in the development of bio and cannabis products. The business model of Corix Bioscience Inc is multifaceted and includes several divisions, with a focus on research and development, manufacturing, and distribution. Research and Development: Corix Bioscience Inc conducts intensive research and development of bio and cannabis products with the aim of developing cleaner medicine and alternative health products. In these efforts, the company focuses on the development of innovative methods for active ingredient extraction and the use of natural ingredients. Manufacturing: The company produces a wide range of products made from organically grown raw materials. In recent years, Corix Bioscience Inc has invested in the growth and processing of cannabis, hemp, and other organic products. These products are manufactured in laboratories and production facilities that are subject to strict controls to ensure full compliance with safety regulations and laws. Another pillar in the manufacturing sector involves the production of CBD oils and extracts. The focus here is on natural and high-quality products that offer customers good and balanced benefits. Distribution: Corix Bioscience Inc distributes its products through various channels, including wholesalers, online retailers, retail stores, and direct sales outlets. The sales strategies are designed to ensure addressing different target groups. Clear positioning and offering the right products ensure successful business. Products: Corix Bioscience Inc distributes a wide range of bio and cannabinoid products. The range includes CBD oil, CBD tincture (also in alcohol), CBD capsules, CBD cosmetics, hemp seeds, hemp oil, and hemp oil capsules. Various lotions, oils, and creams based on natural ingredients are offered in the cosmetics sector. Conclusion: Corix Bioscience Inc has successfully established itself in the market. By investing in research and development, as well as in the production and distribution of bio and cannabis products, the company has been able to develop a diverse range of products. Corix Bioscience Inc places special emphasis on natural products and innovation. As a result, it has gained a loyal customer base that is enthusiastic about the products. In the future, Corix Bioscience Inc should align its strategies towards the future in order to continue to be a commercial success.

Omsætningen kan for øjeblikket ikke beregnes for Corix Bioscience.

Overskuddet kan for øjeblikket ikke beregnes for Corix Bioscience.

P/E-forholdet kan ikke beregnes for Corix Bioscience i øjeblikket.

P/S-forholdet kan ikke beregnes for Corix Bioscience i øjeblikket.

AlleAktien-kvalitetsscore for Corix Bioscience er 3/10.

ISIN for Corix Bioscience er US21887N1037. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Corix Bioscience er A14UX1. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Corix Bioscience er CXBS. Tickersymbolet bruges til at handle Corix Bioscience-aktier på børsen.

Fair værdiTerminal
0,00 USD
Over-/underværdieringTerminal
Fair værdieret
Sektor
Industri
Bioteknologi
Antal aktier
Medarbeidere
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside ahitrust.com
Land
Valuta
USD
Børsintroduktion
8. apr. 2009
ISIN
US21887N1037
CUSIP
21887N103
SEDOL
BF7MQC7
Markedsværdi
852,66 USDMicro Cap
52-ugers interval
AAQS
3 / 10
PEG-forhold
—
P/E-forhold
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
0,00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-46,37 %
Sidst opdateret 21. nov. 2026, 11.15

Corix Bioscience FIGI

CXBS:US · BBG000C8KTC9CXBS:PQ · BBG000C8L0Y7CXBS:UV · BBG000C8L1P5